ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,223Medicare Part D Prescriptions Filled, Including Refills

Rank: 242 out of 2588

$500K Total Retail Price of All Prescriptions

Rank: 468 out of 2588

455 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 455 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

5% of this provider’s 455 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,208 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 697 468 1 1
LISINOPRIL 673 447 2 3
OMEPRAZOLE 609 328 3 6
HYDROCHLOROTHIAZIDE 528 396 4 13
AMLODIPINE BESYLATE 438 336 5 4
OXYCODONE-ACETAMINOPHEN 437 127 S2 6 218
LEVOTHYROXINE SODIUM 340 225 7 2
PRAVASTATIN SODIUM 335 238 8 16
ALENDRONATE SODIUM 325 282 9 21
METFORMIN HCL 313 182 10 8
METOPROLOL TARTRATE 272 181 11 9
OXYCODONE HCL 238 39 S2 12 259
METOPROLOL SUCCINATE 228 160 13 12
ZOLPIDEM TARTRATE 194 96 14 24
FUROSEMIDE 183 129 15 5
PROAIR HFA 180 79 16 50
FENTANYL 160 0 S2 17 78
CRESTOR 157 83 18 25
GABAPENTIN 157 57 18 18
WARFARIN SODIUM 136 115 20 10
GLIPIZIDE 130 110 21 44
ATORVASTATIN CALCIUM 126 90 22 11
FLUTICASONE PROPIONATE 121 57 23 40
SERTRALINE HCL 121 96 23 26
ATENOLOL 116 104 25 14
DIOVAN 108 96 26 29
PANTOPRAZOLE SODIUM 107 36 27 28
LOSARTAN POTASSIUM 100 84 28 17
MORPHINE SULFATE ER 98 0 S2 29 204
TRAMADOL HCL 91 27 30 19
POLYETHYLENE GLYCOL 3350 86 56 31 55
LOVASTATIN 83 76 32 34
TRAZODONE HCL 81 47 33 61
ADVAIR DISKUS 80 47 34 48
ENALAPRIL MALEATE 76 56 35 31
HYDRALAZINE HCL 73 63 36 53
IBUPROFEN 72 18 37 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 44 37 127
CITALOPRAM HBR 71 61 39 27
PAROXETINE HCL 68 42 40 71
AZITHROMYCIN 68 33 40 45
HYDROCODONE-ACETAMINOPHEN 68 16 S3 40 7
INSULIN SYRINGE 67 36 43 81
NAPROXEN 67 25 43 95
DILTIAZEM 24HR ER 62 32 45 166
FLUOXETINE HCL 61 29 46 92
CYCLOBENZAPRINE HCL 58 0 R 47 87
PREDNISONE 57 38 48 42
NIFEDIPINE ER 54 50 49 59
CARISOPRODOL 53 0 R 50 233
TRIAMCINOLONE ACETONIDE 51 29 51 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.